Home
About
Overview
Early and Late Stage Drug Development
Personalized Treatment Recommendations
Mission Statement
Management Team
Medical Advisory Board
Scientific Advisory Board
Board of Directors
Theralink
Theralink Assay Version 1.0
Theralink Technical Information
News & Media
Press Releases
Events
Newsletter
Investors
Investor Relations
Overview
Market Opportunity
News / Events
Press Releases
Calendar
Email Alerts
Company Info
Profile
Management Team
Medical Advisory Board
Scientific Advisory Board
Board of Directors
Contacts
IR FAQ
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Career Opportunities
Contact
Home
Investors
SEC Filings
Annual Reports
Investors
Overview
Market Opportunity
News / Events
Company Information
Stock Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Email Alerts
Annual Reports
Filter Filings:
View All
10-K
NT 10-K
Date
Form
Description
Docs
XBRL
Pages
01/29/13
NT 10-K
Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT
2
02/14/12
10-K
Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-31.1
EX-32.1
42
01/30/12
NT 10-K
Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT
2
02/15/11
10-K
Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-10.3
EX-31.1
EX-32.1
38
01/31/11
NT 10-K
Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT
4
02/16/10
10-K
Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-3.1(B)
EX-3.2
EX-31.1
EX-32.1
40
01/29/10
NT 10-K
Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT
4
<< Previous
1
2
Sign up for email updates
Be the first to receive news and updates
Learn More